BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

AREVA Med LLC Selects Goodwin Biotechnology, Inc. as a Partner for Its New Cancer Treatment


5/18/2009 8:32:14 AM

PLANTATION, Fla.--(BUSINESS WIRE)--Goodwin Biotechnology Inc. (GBI) disclosed today that following its recent formation, AREVA Med LLC has decided to extend its collaboration with GBI toward the development of AREVA Med’s lead-212 (212Pb) initiative to treat cancer. The operation previously engaged with AREVA will continue with AREVA Med and will result in the manufacture of a new conjugated drug that will be radiolabeled by the NCI. AREVA Med will benefit from the vast expertise in the nuclear industry from its parent company that allowed for the production of this radioisotope previously considered a scarce resource.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES